Lv5
1290 积分 2024-01-26 加入
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
1个月前
已完结
Robust meta‐analytic‐predictive priors in clinical trials with historical control information
2个月前
已完结
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma
4个月前
已完结
Trends in the drug target landscape for autoimmune diseases
5个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
5个月前
已完结
Role of thymic stromal lymphopoietin in allergy and beyond
5个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
5个月前
已完结
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4
5个月前
已关闭
The Breathlessness, Cough, and Sputum Scale: The Development of Empirically Based Guidelines for Interpretation
5个月前
已完结
Chronic obstructive pulmonary disease
6个月前
已完结
皖公网安备34019202002308
